P. Tugwell and M. Boers, OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction, J Rheumatol, vol.20, issue.3, pp.528-558, 1993.

L. Frank, E. Basch, and J. Selby, The PCORI Perspective on Patient-Centered Outcomes Research, JAMA, vol.312, issue.15, pp.1513-1517, 2014.
DOI : 10.1001/jama.2014.11100

W. Koroshetz, A core set of trial outcomes for every medical discipline?, BMJ, vol.350, issue.jan26 8, p.85, 2015.
DOI : 10.1136/bmj.h85

P. Williamson, D. Altman, J. Blazeby, M. Clarke, and E. Gargon, Driving up the Quality and Relevance of Research Through the Use of Agreed Core Outcomes, Journal of Health Services Research & Policy, vol.17, issue.1, pp.1-2, 2012.
DOI : 10.1371/journal.pmed.1000393

S. Tunis, M. Clarke, S. Gorst, E. Gargon, J. Blazeby et al., Improving the relevance and consistency of outcomes in comparative effectiveness research, Journal of Comparative Effectiveness Research, vol.11, issue.1, pp.193-205, 2016.
DOI : 10.1186/s13063-015-0738-6

M. Murad, N. Shah, H. Van-houten, J. Ziegenfuss, J. Deming et al., Individuals with diabetes preferred that future trials use patient-important outcomes and provide pragmatic inferences, Journal of Clinical Epidemiology, vol.64, issue.7, pp.743-751, 2011.
DOI : 10.1016/j.jclinepi.2010.08.005

J. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated Available from http, The Cochrane Collaboration, 2011.

J. Ioannidis, Why Most Clinical Research Is Not Useful, PLOS Medicine, vol.174, issue.7, p.1002049, 2016.
DOI : 10.1371/journal.pmed.1002049.t003

I. Chalmers and P. Glasziou, Avoidable waste in the production and reporting of research evidence, The Lancet, vol.374, issue.9683, pp.86-95, 2009.
DOI : 10.1016/S0140-6736(09)60329-9

A. Salman, R. Beller, E. Kagan, J. Hemminki, E. Phillips et al., Increasing value and reducing waste in biomedical research regulation and management, The Lancet, vol.383, issue.9912, pp.176-85, 2014.
DOI : 10.1016/S0140-6736(13)62297-7

I. Chalmers, M. Bracken, B. Djulbegovic, S. Garattini, J. Grant et al., How to increase value and reduce waste when research priorities are set, The Lancet, vol.383, issue.9912, pp.156-65, 2014.
DOI : 10.1016/S0140-6736(13)62229-1

A. Chan, F. Song, A. Vickers, T. Jefferson, K. Dickersin et al., Increasing value and reducing waste: addressing inaccessible research, The Lancet, vol.383, issue.9913, pp.257-66, 2014.
DOI : 10.1016/S0140-6736(13)62296-5

P. Glasziou, D. Altman, P. Bossuyt, I. Boutron, M. Clarke et al., Reducing waste from incomplete or unusable reports of biomedical research, The Lancet, vol.383, issue.9913, pp.267-76, 2014.
DOI : 10.1016/S0140-6736(13)62228-X

J. Ioannidis, S. Greenland, M. Hlatky, M. Khoury, M. Macleod et al., Increasing value and reducing waste in research design, conduct, and analysis, The Lancet, vol.383, issue.9912, pp.166-75, 2014.
DOI : 10.1016/S0140-6736(13)62227-8

M. Macleod, S. Michie, I. Roberts, U. Dirnagl, I. Chalmers et al., Biomedical research: increasing value, reducing waste, The Lancet, vol.383, issue.9912, pp.101-105, 2014.
DOI : 10.1016/S0140-6736(13)62329-6

D. Moher, P. Glasziou, I. Chalmers, M. Nasser, P. Bossuyt et al., Increasing value and reducing waste in biomedical research: who's listening?, The Lancet, vol.387, issue.10027, pp.1573-86, 2016.
DOI : 10.1016/S0140-6736(15)00307-4

Y. Yordanov, A. Dechartres, R. Porcher, I. Boutron, D. Altman et al., Avoidable waste of research related to inadequate methods in clinical trials, BMJ, vol.350, issue.mar24 20, p.809, 2015.
DOI : 10.1136/bmj.h809

V. Smith, M. Clarke, P. Williamson, and E. Gargon,

, J Clin Epidemiol, vol.68, issue.3, pp.237-282, 2014.

G. Gandhi, M. Murad, A. Fujiyoshi, R. Mullan, D. Flynn et al., Patient-Important Outcomes in Registered Diabetes Trials, JAMA, vol.299, issue.21, pp.2543-2552, 2008.
DOI : 10.1001/jama.299.21.2543

K. Rahimi, A. Malhotra, A. Banning, and C. Jenkinson, Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review, BMJ, vol.341, issue.nov01 1, p.5707, 2010.
DOI : 10.1136/bmj.c5707

S. Svensson, D. Menkes, and J. Lexchin, Surrogate Outcomes in Clinical Trials, JAMA Internal Medicine, vol.173, issue.8, pp.611-613, 2013.
DOI : 10.1001/jamainternmed.2013.3037

H. Naci and J. Ioannidis, How Good Is ???Evidence??? from Clinical Studies of Drug Effects and Why Might Such Evidence Fail in the Prediction of the Clinical Utility of Drugs?, Annual Review of Pharmacology and Toxicology, vol.55, issue.1, pp.169-89, 2015.
DOI : 10.1146/annurev-pharmtox-010814-124614

A. Ocana and I. Tannock, When Are "Positive" Clinical Trials in Oncology Truly Positive?, JNCI Journal of the National Cancer Institute, vol.28, issue.24, pp.16-20, 2010.
DOI : 10.1200/JCO.2010.28.9918

C. Gluud and K. Krogsgaard, Would you trust a surrogate respondent?, The Lancet, vol.349, issue.9053, pp.665-671, 1997.
DOI : 10.1016/S0140-6736(05)60131-6

, The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction, N Engl J Med, vol.321, issue.6, pp.406-418, 1989.

O. Ciani, M. Buyse, R. Garside, T. Pavey, K. Stein et al., Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study, BMJ, vol.346, issue.jan29 1, p.457, 2013.
DOI : 10.1136/bmj.f457

R. Moynihan, Surrogates under scrutiny: fallible correlations, fatal consequences, BMJ, vol.343, issue.aug15 1, p.5160, 2011.
DOI : 10.1136/bmj.d5160

S. Walter, X. Sun, D. Heels-ansdell, and G. Guyatt, Treatment effects on patient-important outcomes can be small, even with large effects on surrogate markers, Journal of Clinical Epidemiology, vol.65, issue.9, pp.940-945, 2012.
DOI : 10.1016/j.jclinepi.2012.02.012

A. Chan, A. Hrobjartsson, M. Haahr, P. Gotzsche, and D. Altman, Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials, JAMA, vol.291, issue.20, pp.2457-65, 2004.
DOI : 10.1001/jama.291.20.2457

K. Dwan, D. Altman, L. Cresswell, M. Blundell, C. Gamble et al., Comparison of protocols and registry entries to published reports for randomised controlled trials, Cochrane Database Syst Rev, vol.1, p.31, 2011.

S. Mathieu, I. Boutron, D. Moher, D. Altman, and P. Ravaud, Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials, JAMA, vol.302, issue.9, pp.977-84, 2009.
DOI : 10.1001/jama.2009.1242

P. Williamson and C. Gamble, Identification and impact of outcome selection bias in meta-analysis, Statistics in Medicine, vol.315, issue.3, pp.1547-61, 2005.
DOI : 10.1136/bmj.315.7109.622

J. Kirkham, K. Dwan, D. Altman, C. Gamble, S. Dodd et al., The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews, BMJ, vol.340, issue.feb15 1, p.365, 2010.
DOI : 10.1136/bmj.c365

C. Jones, L. Keil, W. Holland, M. Caughey, and T. Platts-mills, Comparison of registered and published outcomes in randomized controlled trials: a systematic review, BMC Medicine, vol.1, issue.9, p.282, 2015.
DOI : 10.1056/NEJMsa1012065

A. Chan, K. Krleza-jeric, I. Schmid, and D. Altman, Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research, Canadian Medical Association Journal, vol.171, issue.7, pp.735-775, 2004.
DOI : 10.1503/cmaj.1041086

A. Chan and D. Altman, Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors, BMJ, vol.330, issue.7494, p.753, 2005.
DOI : 10.1136/bmj.38356.424606.8F

A. Dechartres, P. Ravaud, I. Atal, C. Riveros, and I. Boutron, Association between trial registration and treatment effect estimates: a meta-epidemiological study, BMC Medicine, vol.6, issue.7, p.100, 2016.
DOI : 10.1371/journal.pmed.1000097

S. Mocellin, M. Lens, S. Pasquali, P. Pilati, C. Sileni et al., Interferon alpha for the adjuvant treatment of cutaneous melanoma, Cochrane Database Syst Rev, vol.6, p.8955, 2013.

H. Ameur, P. Ravaud, F. Fayard, C. Riveros, and A. Dechartres, Systematic reviews of therapeutic interventions frequently consider patient-important outcomes, Journal of Clinical Epidemiology, vol.84, pp.70-77, 2017.
DOI : 10.1016/j.jclinepi.2017.01.006

T. Furukawa, N. Watanabe, I. Omori, V. Montori, and G. Guyatt, Association Between Unreported Outcomes and Effect Size Estimates in Cochrane Meta-analyses, JAMA, vol.297, issue.5, pp.468-70, 2007.
DOI : 10.1001/jama.297.5.468-b

F. Wuytack, V. Smith, M. Clarke, P. Williamson, and E. Gargon, Towards core outcome set (COS) development: a follow-up descriptive survey of outcomes in Cochrane reviews, Systematic Reviews, vol.68, issue.3, p.73, 2015.
DOI : 10.1002/14651858

, The COMET (Core Outcome Measures in Effectiveness Trials) Initiative [http://www.comet-initiative, Accessed 11, 2017.

, Methodology Committee of the Patient-Centered Outcomes Research I. Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective, JAMA, vol.307, issue.15, pp.1636-1676, 2012.

J. Selby, A. Beal, and L. Frank, The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda, JAMA, vol.307, issue.15, pp.1583-1587, 2012.

M. Clarke and P. Williamson, Core outcome sets and trial registries, Trials, vol.346, issue.6, p.216, 2015.
DOI : 10.1136/bmj.e7586

E. Gargon, P. Williamson, D. Altman, J. Blazeby, S. Tunis et al., The COMET Initiative database: progress and activities update (2015), Trials, vol.383, issue.9912, p.54, 2015.
DOI : 10.1016/S0140-6736(13)62227-8

E. Gargon, P. Williamson, D. Altman, J. Blazeby, and M. Clarke, The COMET initiative database: progress and activities update (2014), Trials, vol.20, issue.1, p.515, 2014.
DOI : 10.1038/nm0814-798

E. Gargon, P. Williamson, D. Altman, J. Blazeby, and M. Clarke, The COMET Initiative database: progress and activities from 2011 to 2013, Trials, vol.15, issue.1, p.279, 2014.
DOI : 10.1186/1745-6215-15-279

C. Riveros, A. Dechartres, E. Perrodeau, R. Haneef, I. Boutron et al., Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals, PLoS Medicine, vol.5, issue.12, p.1001566, 2013.
DOI : 10.1371/journal.pmed.1001566.s002

J. Peters and K. Mengersen, Meta-analysis of repeated measures study designs, Journal of Evaluation in Clinical Practice, vol.24, issue.15, pp.941-50, 2008.
DOI : 10.1002/0470870168

J. Useem, A. Brennan, M. Lavalley, M. Vickery, O. Ameli et al., Systematic Differences between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched Pair Analysis, PLOS ONE, vol.330, issue.Suppl 1, p.144980, 2015.
DOI : 10.1371/journal.pone.0144980.s002